Response to Combination Therapy with Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C According to a TNF-α Promoter Polymorphism - Concepedia

Concepedia

Publication | Open Access

Response to Combination Therapy with Interferon Alfa-2a and Ribavirin in Chronic Hepatitis C According to a TNF-α Promoter Polymorphism

DOI Full Paper Access

25

Citations

30

References

2003

Year

U Schiemann, Jürgen Glas, Pavol Török, Christian Simperl, Kathleen Martin, August König, Folkhard Schmidt, Martin Schaefer, C Folwaczny

Abstract

The promoter polymorphism of the TNF-alpha gene investigated herein is equally distributed in healthy individuals and patients with hepatitis C and does not seem to predict the response to therapy with interferon alfa-2a and ribavirin.

References

	Year	Citations

Page 1